Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Study of Anti-PD-1 Antibody MK-3475 and Peginterferon Alfa-2b for Advanced Melanoma

NCT02112032 is registered in ClinicalTrials.gov with Hassane M. Zarour, MD as lead sponsor.

NCT NCT02112032
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02112032 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Study of Anti-PD-1 Antibody MK-3475 and Peginterferon Alfa-2b for Advanced Melanoma
Lead sponsor
Hassane M. Zarour, MD
Phase
Phase 1
Overall status
Completed
Start date
July 24, 2014
Completion date
July 17, 2020
Enrollment
43 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma